Wegovy

WegovyWegovy
Wegovy

Wegovy

Wegovy is a prescription medication containing semaglutide used for chronic weight management in adults.

ActiveBagsværd, Denmark

About

Wegovy is a GLP-1 receptor agonist medication developed by Novo Nordisk for the treatment of obesity and overweight conditions. It functions by mimicking hormones that target areas of the brain that regulate appetite and food intake.
Frequently asked

What does Wegovy do?

Wegovy is a GLP-1 receptor agonist medication developed by Novo Nordisk for the treatment of obesity and overweight conditions. It functions by mimicking hormones that target areas of the brain that regulate appetite and food intake.

Where is Wegovy headquartered?

Wegovy is headquartered in Bagsværd, Denmark.

What industry does Wegovy operate in?

Wegovy operates in Biotech, HealthTech, MedTech, Drug Discovery.

New entrants in Biotech
Last 90 days
37
New entrants
12.3
Per month
2.9
Per week

An entrant is a company tagged Biotech whose domain was first registered in the window, counted from registry records in the StartupHub directory. 8 of them registered in the last 30 days. Registry detection runs two to three weeks behind registration, so recent weeks are a floor.

Scores
Measured, not editorial
Agent Readiness
39/100

How well an AI agent can read and use this site: structured data, clean markup, and whether key facts are reachable without running JavaScript. We scan the live site.

Domain Rating
73/100

Strength of the site’s backlink profile, on the industry-standard 0-100 scale. Licensed third-party data, not our opinion.

Site Speed
40/100

Google PageSpeed mobile performance for the company’s own site. Measured by Google, not by us.

Star ratings come from visitors, one per person per profile, and are shown exactly as given: we do not weight, curate or filter them. Reviews are published in full alongside the rating that accompanied them.

Comments

No comments yet. Be the first to share your take.